annual EBIT:
$206.60M+$488.04M(+173.41%)Summary
- As of today (June 22, 2025), CVAC annual earnings before interest & taxes is $206.60 million, with the most recent change of +$488.04 million (+173.41%) on December 31, 2024.
- During the last 3 years, CVAC annual EBIT has risen by +$682.43 million (+143.42%).
- CVAC annual EBIT is now at all-time high.
Performance
CVAC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$54.00M-$12.22M(-29.25%)Summary
- As of today (June 22, 2025), CVAC quarterly earnings before interest & taxes is -$54.00 million, with the most recent change of -$12.22 million (-29.25%) on March 1, 2025.
- Over the past year, CVAC quarterly EBIT has increased by +$21.54 million (+28.51%).
- CVAC quarterly EBIT is now -113.25% below its all-time high of $407.71 million, reached on September 30, 2024.
Performance
CVAC quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$235.38M+$21.54M(+10.07%)Summary
- As of today (June 22, 2025), CVAC TTM earnings before interest & taxes is $235.38 million, with the most recent change of +$21.54 million (+10.07%) on March 1, 2025.
- Over the past year, CVAC TTM EBIT has increased by +$528.68 million (+180.26%).
- CVAC TTM EBIT is now at all-time high.
Performance
CVAC TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CVAC EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +173.4% | +28.5% | +180.3% |
3 y3 years | +143.4% | -263.3% | +164.6% |
5 y5 years | +287.0% | -120.7% | +375.1% |
CVAC EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +143.4% | -113.3% | +59.2% | at high | +164.6% |
5 y | 5-year | at high | +143.4% | -113.3% | +69.6% | at high | +144.0% |
alltime | all time | at high | +143.4% | -113.3% | +69.6% | at high | +144.0% |
CVAC EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$54.00M(+29.2%) | $235.38M(+10.1%) |
Dec 2024 | $206.60M(-173.4%) | -$41.78M(-110.2%) | $213.85M(+32.2%) |
Sep 2024 | - | $407.71M(-632.7%) | $161.76M(-154.2%) |
Jun 2024 | - | -$76.54M(+1.3%) | -$298.30M(+1.7%) |
Mar 2024 | - | -$75.54M(-19.5%) | -$293.29M(+5.3%) |
Dec 2023 | -$281.44M(+8.1%) | -$93.87M(+79.3%) | -$278.40M(-12.2%) |
Sep 2023 | - | -$52.35M(-26.8%) | -$316.98M(+1.6%) |
Jun 2023 | - | -$71.54M(+18.0%) | -$312.08M(+3.6%) |
Mar 2023 | - | -$60.65M(-54.2%) | -$301.23M(+17.9%) |
Dec 2022 | -$260.33M | -$132.45M(+179.1%) | -$255.45M(+99.8%) |
Sep 2022 | - | -$47.45M(-21.8%) | -$127.85M(-48.3%) |
Jun 2022 | - | -$60.69M(+308.3%) | -$247.31M(-32.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$14.86M(+206.8%) | -$364.36M(-24.2%) |
Dec 2021 | -$475.83M(+286.7%) | -$4.84M(-97.1%) | -$480.70M(-10.2%) |
Sep 2021 | - | -$166.91M(-6.1%) | -$535.08M(+31.6%) |
Jun 2021 | - | -$177.74M(+35.5%) | -$406.63M(+75.1%) |
Mar 2021 | - | -$131.20M(+121.5%) | -$232.20M(+85.1%) |
Dec 2020 | -$123.05M(+11.4%) | -$59.23M(+54.0%) | -$125.47M(+16.6%) |
Sep 2020 | - | -$38.46M(+1059.3%) | -$107.63M(+21.1%) |
Jun 2020 | - | -$3.32M(-86.4%) | -$88.88M(+3.9%) |
Mar 2020 | - | -$24.47M(-40.9%) | -$85.56M(+0.6%) |
Dec 2019 | -$110.46M(+32.0%) | -$41.38M(+110.0%) | -$85.03M(+94.8%) |
Sep 2019 | - | -$19.71M(-17.7%) | -$43.65M(+82.3%) |
Mar 2019 | - | -$23.94M | -$23.94M |
Dec 2018 | -$83.67M | - | - |
FAQ
- What is CureVac NV annual earnings before interest & taxes?
- What is the all time high annual EBIT for CureVac NV?
- What is CureVac NV annual EBIT year-on-year change?
- What is CureVac NV quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for CureVac NV?
- What is CureVac NV quarterly EBIT year-on-year change?
- What is CureVac NV TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for CureVac NV?
- What is CureVac NV TTM EBIT year-on-year change?
What is CureVac NV annual earnings before interest & taxes?
The current annual EBIT of CVAC is $206.60M
What is the all time high annual EBIT for CureVac NV?
CureVac NV all-time high annual earnings before interest & taxes is $206.60M
What is CureVac NV annual EBIT year-on-year change?
Over the past year, CVAC annual earnings before interest & taxes has changed by +$488.04M (+173.41%)
What is CureVac NV quarterly earnings before interest & taxes?
The current quarterly EBIT of CVAC is -$54.00M
What is the all time high quarterly EBIT for CureVac NV?
CureVac NV all-time high quarterly earnings before interest & taxes is $407.71M
What is CureVac NV quarterly EBIT year-on-year change?
Over the past year, CVAC quarterly earnings before interest & taxes has changed by +$21.54M (+28.51%)
What is CureVac NV TTM earnings before interest & taxes?
The current TTM EBIT of CVAC is $235.38M
What is the all time high TTM EBIT for CureVac NV?
CureVac NV all-time high TTM earnings before interest & taxes is $235.38M
What is CureVac NV TTM EBIT year-on-year change?
Over the past year, CVAC TTM earnings before interest & taxes has changed by +$528.68M (+180.26%)